Analysis of invasive pneumonia-causing strains of Streptococcus pneumoniae: serotypes and antimicrobial susceptibility

Objectives: To identify the most common pneumococcal serotypes in children hospitalized with invasive pneumonia, correlate isolated serotypes with those included in conjugate vaccines, and ascertain the sensitivity of the isolated pneumococcal strains to penicillin and other antibiotics. Methods: From January 2003 to October 2008, a retrospective study of hospitalized children with a diagnosis of Streptococcus pneumoniae pneumonia was conducted at the university hospital of Universidade de Sao Paulo. Criteria for inclusion were: age greater than 29 days and less than 15 years, radiological and clinical diagnosis of pneumonia, and isolation of Streptococcus pneumoniae in blood cultures and/or pleural effusion. Results: The study included 107 children. The most common serotypes were 14 (36.5%), 1 (16%), 5 (14.6%), 6B (6.3%) and 3 (4.2%). The proportion of identified serotypes contained in the heptavalent, 10-valent and 13-valent conjugate vaccines was 53.1, 86.5, and 96.9%, respectively. Pneumococcal strains were sensitive to penicillin (minimum inhibitory concentration, MIC <= 2 mu g/mL) in 100 cases (93.5%) and displayed intermediate resistance (MIC = 4 mu g/mL) in 7 cases (6.5%). No strains were penicillin-resistant (MIC >= 8 mu g/mL) according to the Clinical and Laboratory Standards Institute 2008 standards. Tested isolates were highly sensitive to vancomycin, rifampicin, ceftriaxone, clindamycin, erythromycin, and chloramphenicol. Conclusions: Our results confirm a significant potential impact of conjugate vaccines, mainly 10-valent and 13-valent, on invasive pneumonia. Furthermore, susceptibility testing results show that penicillin is still the treatment of choice for invasive pneumonia in our setting.

Palavras-chave

Streptococcus pneumoniae, pneumonia, serotype, antimicrobial resistance, pneumococcal conjugate vaccine

URI

https://observatorio.fm.usp.br/handle/OPI/23298

Referências

FRIEDLAND IR, 1992, AM J DIS CHILD, V146, P920
Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820
[Anonymous], 1997, PEDIATRICS, V99, P289
Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603
Di Fabio JL, 2001, PEDIATR INFECT DIS J, V20, P959, DOI 10.1097/00006454-200110000-00009
Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P1353
Heffelfinger JD, 2000, ARCH INTERN MED, V160, P1399, DOI 10.1001/archinte.160.10.1399
PALLARES R, 1995, NEW ENGL J MED, V333, P474, DOI 10.1056/NEJM199508243330802
Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608
Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8
Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769
Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895
Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534
Brandileone MCC, 2006, J MED MICROBIOL, V55, P567, DOI 10.1099/jmm.0.46387-0
Song JH, 2004, CLIN INFECT DIS, V38, P1570, DOI 10.1086/420821
Berezin EN, 1996, PEDIATR INFECT DIS J, V15, P1051, DOI 10.1097/00006454-199611000-00027
Bryan CS, 1997, CHEST, V112, P1657, DOI 10.1378/chest.112.6.1657
Castaneda E, 2009, PEDIATR INFECT DIS J, V28, P265, DOI 10.1097/INF.0B013E3181A74B22
Clinical and Laboratory Standards Institute, 2008, CLSI PUBL, V28
Giachetto G, 2004, PEDIATR INFECT DIS J, V23, P625, DOI 10.1097/01.inf.0000128783.11218.c9
Hathaway LJ, 2007, MICROBIOL-SGM, V153, P2465, DOI 10.1099/mic.0.2006/005066-0
Nascimento-Carvalho Cristiana N, 2003, J Pediatr (Rio J), V79, P209, DOI 10.1590/S0021-75572003000300005
*ORG PAN SALUD, 2009, INF REG SIR 2008 DAT
PALLARES R, 1987, NEW ENGL J MED, V317, P18, DOI 10.1056/NEJM198707023170104
Shouval DS, 2009, PEDIATR INFECT DIS J, V28, P277, DOI 10.1097/INF.0b013e31818e0e2e
Wolkers PCB, 2009, J PEDIAT-BRAZIL, V85, P421, DOI [10.2223/JPED.1931, 10.1590/S0021-75572009000500009]

Coleções

Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - HU

Página do item completo